Abstract
Background High-quality, longitudinal data from the Emergency Department (ED) are essential for understanding acute illness trajectories and for developing clinically deployable prediction models. However, most existing ED datasets are static, limited in modality or disconnected from long-term outcomes or biomaterials.
Methods We describe a two-year sample of Acutelines, a continuously operating ED-based data-biobank infrastructure at the University Medical Center Groningen. Acutelines is embedded in routine care and captures the full acute care trajectory and uses a stepped consent procedure. It integrates demographics, vital signs, laboratory results, diagnoses, treatments, waveforms, patient-reported outcomes, and prospectively collected biomaterials. Data are linked to in-hospital outcomes and post-discharge mortality.
Results The presented dataset comprises 29,314 ED visits from 18,850 adult patients. Clinical variables are available for nearly all visits, with additional data and questionnaires (n=4,963) and biomaterials (n=2,723) collected in predefined subgroups. Associations between early triage features (National Early Warning Score, vital signs, diagnostic categories) and outcomes, illustrate the clinical depth and longitudinal value of the infrastructure.
Conclusion Acutelines is a living, continuously expanding research infrastructure. Its combination of ED-first inclusion, multimodal data, linkage to long-term outcomes, and availability of biomaterials distinguishes it from existing datasets. Acutelines provides a robust foundation for hypothesis generation, translational research, and the development, validation, and benchmarking of data-driven clinical decision support tools and biomarker tests in acute medicine, while its ongoing expansion enables prospective studies and interventional research.
Trial registration Acutelines is registered at ClinicalTrials.gov under trial registration number NCT04615065.
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All procedures are approved by the institutional review board (#201900635) and comply with national and European regulations on medical research and data protection. The current Acutelines resource description was approved by the ethics committee of the UMCG (#23514).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
